Anti-hyperglycemic drug comes to the rescue of blood-stage Plasmodium infection: Ciglitazone, an anti-hyperglycemic drug,  decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clears blood-stage malaria, via up regulation of its target gene, 17/July/2018, 5,50 pm